Stocks and Investing Stocks and Investing
Thu, March 18, 2021
Wed, March 17, 2021
Tue, March 16, 2021
Mon, March 15, 2021
Sun, March 14, 2021
Fri, March 12, 2021
Thu, March 11, 2021

Tiago Fauth Maintained (ASND) at Buy with Decreased Target to $176 on, Mar 11th, 2021


Published on 2024-10-27 15:55:22 - WOPRAI, Tiago Fauth
  Print publication without navigation


Tiago Fauth of Credit Suisse, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Decreased Target from $178 to $176 on, Mar 11th, 2021.

Tiago has made no other calls on ASND in the last 4 months.



There are 2 other peers that have a rating on ASND. Out of the 2 peers that are also analyzing ASND, 0 agree with Tiago's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Tiago


  • David Lebovitz of "Morgan Stanley" Maintained at Buy with Increased Target to $199 on, Friday, November 13th, 2020
  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $191 on, Thursday, November 12th, 2020